Occudo Quantitative Strategies’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-28,111
Closed -$336K 1244
2023
Q2
$336K Buy
28,111
+17,007
+153% +$192K 0.03% 706
2023
Q1
$130K Buy
+11,104
New +$162K 0.01% 795
2022
Q3
Sell
-163,302
Closed -$2.57M 1373
2022
Q2
$2.57M Sell
163,302
-252,227
-61% -$4.24M 0.21% 128
2022
Q1
$6.43M Buy
+415,529
New +$5.24M 0.54% 1
2021
Q4
Sell
-14,119
Closed -$127K 1220
2021
Q3
$127K Sell
14,119
-2,045
-13% -$16.6K 0.02% 905
2021
Q2
$161K Sell
16,164
-2,419
-13% -$20.5K 0.02% 750
2021
Q1
$132K Sell
18,583
-59,417
-76% -$419K 0.03% 672
2020
Q4
$410K Buy
+78,000
New +$307K 0.13% 309

Other funds holding PTEN

Occudo Quantitative Strategies's PTEN Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Patterson-UTI (PTEN) in Q3 2023, closing a stake of 28,111 shares — an estimated $336K sold.

Occudo Quantitative Strategies first reported a position in PTEN in Q4 2020 and held it in 8 quarters. The position peaked at $6.43M in Q1 2022. 357 funds tracked by Wall St. Rank hold PTEN as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Patterson-UTI position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 28,111 Patterson-UTI shares in Q3 2023, an estimated $336K.
  • Occudo Quantitative Strategies first reported a position in Patterson-UTI in Q4 2020 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Patterson-UTI position peaked at $6.43M in Q1 2022.
  • 357 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.